Mycotoxins and Disease in Egypt

References

• Badria F. A. A Multidisciplinary Study to Monitor Mycotoxins in Egypt. J. Toxicology-Toxin-Reviews 1996; 15(3)273–292
   Web of Science ®Google Scholar
• Badria F. A., El-Sharkawy S. H., Selim M., Halim A. F. Multimycotoxin detection and quantitation in Egyptian foods and feeds. Abstr. Book Int. Symp and Workshop on food contamination. Mycotoxins, CairoEgypt 1992; 38
   Google Scholar
• El-Bazza Z. E., Zedan H. H., Toama M. A., El-Tayeb O. M. Isolation of Aflatoxin-Producing Fungi: from Egyptian Food and Feed Commodities. Proc. Int. Symp. Myctoxins. Cairo 1983; 443–454
   Google Scholar
• El-Khadem M., Naguib KH., Naguib M. M. Aflatoxins in foodstuff in Egypt. 11. Broad Beans Mycoflora and Toxicity. Proc. Int. symp. Mycotoxins. Cairo 1983; 213–220
   Google Scholar
• Girgis A. N., El-Sherif S., Rofael N., Nesheim S. Aflatoxin in Egyptian Food. Journal of AOAC; 1977; 60: 746–747
   Google Scholar
• Naguib M. M., Naguib KH., El-Khadem M. Aflatoxins in foodstuff in Egypt. I. Broad beans mycoflora and toxicity. Second Arab Congress of Food Technology, Riyadh. 1979
   Google Scholar
• Qutet El-Tayeb S. M. S. A. M., Mosallam A. S. Occurrence of aflatoxins in some Egyptian food crops collected from two coastal regions. Food Chemistry 1983; 110: 149–153
   Google Scholar
• Zakaria M. Z. Aflatoxin residues in ration, eggs and animal tissues obtained from chickens flocks in Assuit Province. M.V.Sc. Thesis, Assuit Faculty of Vet. Med. Assuit, Egypt 1985
   Google Scholar
• Khafagy M. A., Badria F. A. Human Exposure to Aflatoxins ard Hepatocellular Carcinoma: A Case-Control Study in Mansoura Province. Egypt. J. Comm. Med. 1996; 14(1)69–76
   Google Scholar
• Badria F. A., Amer M. A., Agwa H. A. A Comprehensive Screening of Aflatoxins in Egyptian Animal Feeds. Zagazig Journal of Pharmaceutical Sciences 1994; 3(1)92–95
   Google Scholar
• Zohri A. A., Abdel-Gawad E. A. M. Survey of Mycoflora and Mycotoxins of Some Dried Fruits in Egypt. J. Basic Microbiology 1993; 33: 279
   PubMed Web of Science ®Google Scholar
• El-Sagheer G. M. The relatioriship between HBV, aflatoxin and HCC, M.Sc. Thesis, Tropical Medicine, Faculty of Medicine. AinShams University, Egypt 1990
   Google Scholar
• Abaza H., El-Mallah S., El-Kady A., Helmy M., Yehia N., Assal A., El-Deeb S. Mycotoxins and Hepatocellular Carcmoma in Egypt, Abstract Book. Int. Symp. and Workshop on Food Contamination Mycotoxins. CairoEgypt 1992; T26
   Google Scholar
• Saadi M. G., Abdalla E. A. M., Fadel F. I., Francis M., El-Ghadban H., Abdel-Khalek M. K. Prevalence of Ochratoxin-A (OTA) among Egyptian children and Adults with difference Renal Diseases. The Egyptian Society of Nephrology, Dahab, Egyp 1995; T22
   Google Scholar
• Wafa E. W., Yahya R. S., Sobh M. A., El-Baz El-Gayar H. M., Betbeder A. M., Creppy E. E. Human Ochratoxicosis and Nephropathy in Egypt: A preliminary study. Human & Experimental Toxicology 1998; 17: 124–9
   PubMed Web of Science ®Google Scholar
• Wattenberg E. V., Badria F. A., Shier W. T. Activation of mitogen-activated protein kinase by the carcinogen mycotoxin fumorisin B1. Biochem. Biophys. Res. Comm. 1996; 227: 622–627
   PubMedGoogle Scholar
• Badna F. A., Shier W. T. Fate of Fumonisin During Food Processing. The 37th Annual meeting of the Amencan Society of Pharmacognosy (ASP) at the University of California. Santa Cruz July 27 to 31, 1996; 37
   Google Scholar
• Badria F. A., Shier W. T. Racemization of the side chains as an approach to determining their role in the biological activity of the mycotoxin fumonisin B1. 37th Annual meeting of the American Society of Pharmacognosy (ASP) at the University of California. Santa Cruz July 27 to 31, 1996; 137
   Google Scholar
• Badria F. A., Shier W. T. Methionine is a precursor in the biosynthesis of methyl branches in fumonisin B1 by Fusariurn moniliforme and of AAL-toxins by Altemaria alternata. 37th Annual meeting of the American Society of Pharmacognosy (ASP) at the University of California. Santa Cruz July 27 to 31, 1996; 138
   Google Scholar
• Shier W. T., Abbas H. K., Badna F. A. Structure-Activity Relationships of the Com Fungal Toxin Fumonisin B1: Implication for Food Safety. J. Toxicology-Toxin Reviews 1996, In Press
   Google Scholar
• Badria F. A., Li S., Shier W. T. Fumonisins As Potential Causes of Kidney Disease. J. Toxicology-Toxin Reviews 1996; 15(3)251–272
   Google Scholar
• Badria F. A., Abbas H. K., Shier W. T. Chemical Transformation of Hydrolyzed Fumonisin B1 to Hydrolyzed Fumonisin B2. J. Agric. Food Chem. 1995; 43: 1198–1201
   Google Scholar
• Badna F. A., Shier W. T. Where Does Fumonisin Go During Food Processing?. Gordon Conference on Mycotoxins and Phycotoxins; Plymouth State College. N. Plymouth, New Hampshire 1995
   Google Scholar
• Shier W. T., Badna F. A., Abbas H. K. Structure-Activity Relationships for Sphingosine Analog Mycotoxins Fumonisin B1 and AAl-Toxin;. Gordon Conference on Mycotoxins and Phycotoxins; Plymouyh State College. N. Plymouth, New Hampshire 1995
   Google Scholar
• Shier W. T., Abbas H. K., Badria F. A. The Complete Structures of the Sphingosine Analog Mycotoxins Fumonisin B1 and AALToxin TA: Absolute Configuration of the Side Chains;. Tetrahedron Letters 1995; 36(10)1571–1574
   Web of Science ®Google Scholar
• Shier W. T., Hoye Jimenez T. J., Badna F. The Complete Absoulte Stereochemistry of the Mycotoxin Fumonisin B1, A Putative Environmental Tumor Promoter Produced by Fusarium rnoniliforme. VIIIth International Symposium on Toxic Microorganisms “Molecular Approaches to Food Safety Issues involving Toxic Microorganisms”. Holiday Inn City Center, Peoria, ILUSA November, 1994; 15–17
   Google Scholar
• Abbas H. K., Duke S. O., Shier W. T., Badna F. A., Ocamb C. M., Woodward R. P., Xie W., Mrocha C. J. Comparison of Ceramide Synthase Inhibitors with Others Phytotoxins produced by Fusaruium species. J. Nat. Toxins 1997; 6(2)163–180
   Google Scholar
• Shamaa S., El-Bedawy A., Azzam F., Harned M., Shehab El-Din M., Aita M. Hepatocellular Carcinoma in Egypt: Analysis of 192 cases. Egypt. Nat. Canc. Inst. 1992; 5(4)761
   Google Scholar
• Amal El-Gayar, Farid Badria A. Sameh Shamaa, Magdi Hamid and Mahfouz Aim; Serum and Urinary Pseudouridine as Tumor Marker for Hepatocellular Carcinoma. Egyp. J. Tumor Marker Oncology 1994; 5(2)17–21
   Google Scholar
• El-Zayadi A. Primary Hepatic Malignancies in Egypt. African Newslett on Occup Health and Safety Supplement 1993; 2: 42
   Google Scholar
• Sobh M, Moustafa F, Ghoneim M. Value of Renal Biopsy in Chronic Renal Failure. International Urology and Nephrology 1988; 20(1)77–83
   PubMedGoogle Scholar
• Robens J. F., Richard J. L. Aflatoxin in animal and human health. Rev. Environ. Contam. Toxicol 1992; 127: 69–94
   PubMed Web of Science ®Google Scholar
• Coulter J. B. S., Hendrickse Lamplugh R. G. S. M., Macfarlane S. B. J., Moody J. B., Omer M. I. A., Suliman G. I., William T. E. Aflatoxins and kwashiorkor: clinical studies in Sudanese children. Trans. R. Soc. Trop. Med. Hyg 1986; 80: 945–952
   PubMed Web of Science ®Google Scholar
• Krishnamachari K. A., Bhat R. V., Nagarajan V., Tilak T. B.G. Investigation into an outbreak of hepatitis in parts of Western India. Indian. J. Med. Res 1974; 63: 1030–1040
   Google Scholar
• Krishnamachari K. A., Bhat R. V., Nagarajan V., Tilak T. B.G. Hepatitis due to aflatoxicosis., An outbreak in Western India. Lancet 1975; 1: 1061–1062
   PubMed Web of Science ®Google Scholar
• Olson L. C., Bourgeouis C. H., Cotton R. B., Harikul S., Grossman R. A., Smith T. J. Encephalopathy and fatty degeneration of the viscera in north eastern Thailand. Clinical syndrome and epidemiology. Pediatrics 1971; 47: 701–716
   Google Scholar
• Dvorackova I., Brodsky F., German J. Aflatoxin and encephuliric syndrome with fatty degeneration of viscera. Nutr. Rep. Int 1974; 10: 89–102
   Google Scholar
• Ngindu A., Kenya P., Ocueng D., Omond T., Negre W., Johnson B. K., Ngira J. A., Jansen A. J., Kavtti J. N. Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya. Lancet; 1982; 12: 1346–1348
   Google Scholar
• Amla I. J., Kamala C. S., Dopalakrishna G. S., Jayaraj P., Sreenivasa Murthy V., Parpia H. A.B. Cirrhosis in children from peanut meal contaminated by aflatoxin. Am. J. Clin. Nut. 1971; 24: 609–614
   PubMed Web of Science ®Google Scholar
• Amla I. J., Sreenivasa Murthy V., Jayaraj P., Parpia H. A.B. Aflatoxin and Indian childhood cirrhosis. J. Trop. Ped. Environ. Child Health 1974; 19: 28–33
   Google Scholar
• Coulter J. B. S., Hendrickse R. G., Lamplugh S. M., Macfarlane S. B. J., Williams T. E., Omer M. I. A., Suliman G. I. Aflatoxins and Kwashiorkor, A study in Sudanese children. Br. Med. J. 1982; 285: 843–846
   PubMedGoogle Scholar
• El-Bazza Z. E., Zedan H. H., Toama M. A., El-Tayeb O. M. Factors affecting aflatoxin production by a local strain of Aspergillus flavus Proc. Int. Symp. Mycotoxins. Cairo 1983; 231–242
   Google Scholar
• Hendrickse R. G., De Vries H. R., Maxwell S. M. Aflatoxins excretion in children with kwashiorkor or marasmic kwashiorkor: a clinical investigotion. Mycopathologia 1990; 110: 1–9
   PubMedGoogle Scholar
• Coulter J. B. S., Suliman G. I., Lamplugh S. M., Mukhtar R. I., Hendrickse R. G. Aflatoxins in liver biopsies from Sudanese children. Am. J. Trop. Med. Hyg. 1986; 35: 360–365
   PubMed Web of Science ®Google Scholar
• Coward N. A., Lunn P. G. The biochemistry and physiology of kwashiorkor and marasmus. Br. Med. Bull. 1981; 37: 19–24
   PubMed Web of Science ®Google Scholar
• Zabra A., Wild C. P., Hall A. J., Montesano R., Hudson G. J., Groopman J. D. Aflatoxin M1 in human breast milk from the Gambia, West Africa. quantified by combined monoclonal antibody immunoaffinity chromatography and high performance liquid chromatography. Carcinogenesis 1992; 13: 891–894
   PubMedGoogle Scholar
• Lamplugh S. M., Apeagyei F., Mwannmut D., Henrickise R. G. Aflatoxin in breast milk, neonatal cord blood md serum of pregnant women. Br. Med. J 1988; 290–298
   Google Scholar
• Hendnckse R. G., Maxwell S. M. Heroin addicts. AIDS and aflatoxin. Med. J. 1989; 296: 125
   Google Scholar
• Hendrickse R. G., Maxwell S. M., Young R. H. Aflatoxins and heroin. Br. Med. J. 1989; 299: 492–493
   PubMedGoogle Scholar
• Hendrickse R. G. Clinical implications of food contaminated by aflatoxins. Ann. Acad. Med. Singapore, 20: 84–90
   PubMedGoogle Scholar
• Dennis W., Wilson R., Wayne Ball., Roger A., Coulombe J. R. Comparative action of afilatoxin B1 in mammalian airway epithelium. Cancer. Res. 1990; 50: 2493–2498
   PubMedGoogle Scholar
• Alpert M. F., Hutt M. S. R., Wogan G. N., Davidson C. S. Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer 1971; 28: 253
   PubMed Web of Science ®Google Scholar
• Bechtel D. H. Molecular dosimetry of hepatic aflatoxin B1-DNA adduct: Linear correlation with hepatic cancer risk. Regul. Toxicol. Pharmacol. 1989; 10: 74–81
   PubMed Web of Science ®Google Scholar
• Hoseyni M. S. Risk assessment for aflatoxin modeling the relative risk of hepatocellular carcinoma. Risk Anal. 1992; 12: 123–128
   PubMed Web of Science ®Google Scholar
• Sherlock S., Dooley G. Diseases of the liver and biliary system4th ed. Blackwell Scientific Publication. 1993; S503
   Google Scholar
• Wild C. P. Aflatoxin as a human hepatocarcinogen and the possible interaction with hepatitis B virus. African Newslett on Occup Health and Safty Supplement 1993; 2: 24–31
   Google Scholar
• Yan R. Q. A study on primary liver cancer in treeshrews induced by human hepatitis B virus and aflatoxin B1. Chung. Hua. Ping. Li. Hsueh. Tsa. Chin. 1989; 18: 19–22
   Google Scholar
• Ross P. K., Yuan J. M., Yu M. C., Wogan G. N., Qian G. S., Tu J. T., Groopman J. D., Gao Y. T., Henderson B. E. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet 1992; 339: 943–946
   PubMed Web of Science ®Google Scholar
• Wild C. P., Hudson G. J., Sabbioni G., Chapot B., Hall A. J., Wogan G. N., Whittle H., Montesano R., Groopman J. D. Dietary intake of aflatoxins and the level of albumin bound aflatoxin in peripheral blood in the Gambia, West Africa. Cancer. Epidemiol. Biomarker Prev. 1992; 1: 229–234
   PubMed Web of Science ®Google Scholar
• Badna F. A., El-Gayar A., Shamaa S., Abu-Hashem I., Aita M. Serum and Urinary Aflatoxins in Egyptian Patients with Liver Cirrhosis and Heparocellular Carcinoma. Egyp. J. Tumor Marker Oncology 1995; 5(1)27–33
   Google Scholar
• Groopman J. D., Roebuck B. D., Kensler T. W. Molecular dosimetry of aflatoxin DNA adducts in humans and experimental rat models. Prog. Clin. Biol. Res. 1992; 374: 139–155
   PubMedGoogle Scholar
• Wogan G. N. Aflatoxin as risk factor for hepatocellular carcinoma in humans. Cancer. Res. 1992; 52: 2114–2118
   PubMed Web of Science ®Google Scholar
• Campbell T. C., Stoloff L. Implications of mycotoxins for human health. J. Agric. Food. Chem. 1974; 22: 1006–1015
   PubMed Web of Science ®Google Scholar
• Okuda K., Nakashima T., Obata H., Kubo Y. Primary liver cancers in Japan. Cancer 1980; 45: 2663–2669
   PubMed Web of Science ®Google Scholar
• Lim R. C., Bongard F. S. Hepatocellular carcinoma. Changing concepts in diagnosis and managment. Arch. Surg. 1983; 119: 637–641
   Google Scholar
• Nagasue N., Ogawa Y., Yukaya H., Otha N., Ito A. Serum levels of oestrogens and testosterone in cirrhotic man with and without hepatocellular carcinoma. Gastroentrology 1985; 88: 768–772
   PubMedGoogle Scholar
• Maxwell S. M., Apeagyet F., De Vries A. R. Aflatoxins in breast milk, neonatal cord blood and sera of pregnant women. J. Toxicol Toxin. Rev. 1989; 8: 19–29
   Web of Science ®Google Scholar
• Zarnan S., Johnson P., Johnson R., Portman B., Williams R. Risk factor in development of hepatocellular carcinoma in cirrhosis. Prospective study of 613 patients. Lancet 1985; 15: 1357–1354
   Google Scholar
• Hussein M. Study of commonly used synthetic carcinogens in primary hepatocellular carcinoma. M.D. Thesis, Int. Med. Mansoura Faculty of Medicine, Mansoura., Egypt 1992
   Google Scholar
• McIntyre N., Benharnou J. P., Bircher J., Rizzetto M., Rodes J. Oxford textbook of clinical hepatology. Oxford University Press. 1991; volume: 2
   Google Scholar
• Cole K. E., Jones T. W., Lipsky M. M., Trump B. F., Hsu I. C. In vitro binding of aflatoxin B1 and 2– acetylaminofluorene to rat. mouse and human hepatocyte DNA: the relationship of DNA binding to carcinogenicity. Carcinogenesis 1988; 9: 711–716
   PubMed Web of Science ®Google Scholar
• Shafritz D. A., Kew M. C., Stadler G. A. Identification of integrated hepatiris B virus DNA sequences in human hepatocellular carcinoma. Hepatology 1981; 1: 1–8
   PubMedGoogle Scholar